BancFirst Corporation heads into Thursday's Q1 earnings call with its chairman selling millions of dollars of stock into a six-week rally — and options traders positioning with unusual bullishness for a regional bank on the cusp of a report.
The insider angle is the headline this week. Chairman David Rainbolt sold just over 42,000 shares across four sessions from April 23 through April 28, raising roughly $4.97 million at prices around $115.50. That is a concentrated cluster of selling — four trades in six days — from the company's largest individual holder, who still controls nearly 30% of shares outstanding. Rainbolt's net sales over the past 90 days total around 46,000 shares, worth approximately $5.3 million. The Chief Risk Officer also sold 3,000 shares in February. The pattern is consistent with insider distribution into a stock that has rallied 7% over the past month to close Tuesday at $114.15.
Options positioning tells a sharply different story, and the contrast is worth naming. The put/call ratio has collapsed to 0.20 — near the lowest reading of the past year, against a 52-week high of 1.08 — and sits roughly 1.4 standard deviations below its 20-day average of 0.54. A month ago the PCR was running above 0.80. That is a dramatic rotation: investors who were hedging defensively have either taken those puts off or replaced them with calls ahead of Thursday's release. The setup looks more bullish in options than at any point since at least last March.
Short interest is not driving the narrative here, but the direction of travel is noteworthy. Shorts trimmed aggressively through the week, with estimated shares short falling nearly 8% over seven days to around 972,000 — representing just under 3% of the free float, a modest level for any regional bank. The borrow market reflects little pressure: cost to borrow runs at 0.54% annually, down 7.6% on the week, and the lending pool remains loose with ample availability. The ORTEX short score has drifted lower all month, from 47.1 on April 15 to 44.9 today, consistent with positioning that is becoming less bearish rather than more.
The Street remains firmly on the fence. DA Davidson reiterated Neutral with a $125 target on April 20, the most recent action. Keefe, Bruyette & Woods holds Market Perform at $123. Piper Sandler carries an Underweight. The mean target of $124 implies roughly 9% upside from current levels — a modest cushion. Valuation has re-rated upward over the past month: the P/E multiple has expanded by about 0.28 turns to 15.6x, and price-to-book has moved to 1.83x, up 0.08 turns in thirty days. On EPS momentum, BancFirst ranks in the 83rd percentile on a 30-day basis, suggesting estimate revisions have been running in the bulls' favour into the print. The bear case from analysts centres on fee income headwinds and a still-elevated efficiency ratio around 54%, while the bull case rests on NIM expansion, strong capital and M&A optionality.
Earnings history adds texture. The April 16 release — the most recent event — produced a 3.3% gain on the day and a 1.7% five-day drift higher. Before that, the January print delivered a 7.5% drop on day one and a 6.3% loss over five days. The two prior quarters before January were broadly flat to slightly negative on the week. That asymmetric history — one large down, one moderate up, two quiet — gives no clean pattern to lean on.
Peers moved more decisively on the week: BANR gained 5.5% and HBNC added 4%, while BANF was essentially flat. Regional bank sentiment broadly firmed, which means BANF's muted weekly performance came in a rising tide — something worth tracking if the earnings release disappoints on fee income or guidance.
What to watch Thursday is whether the NIM story holds and whether management's commentary on loan growth and credit quality shifts the Street off its firmly neutral stance — the gap between chairman selling at $115 and analyst targets clustered at $123-$125 is where the tension resolves.
See the live data behind this article on ORTEX.
Open BANF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
